Study on the intermolecular interactions in rifampicin ternary solutions — Calculation of microscopic parameters of rifampicin molecules

Nădejde, Claudia; Creangă, Dorina; Humelnicu, Ionel; Filip, Elena; Dorohoi, Dana Ortansa

doi:10.1016/j.molliq.2009.09.012

Search citation statements

Order By: Relevance

Paper Sections

Select...

XLIX1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2010

2018

Publication Types

Select...

Article7

Relationship

Self Cite0

Independent7

Authors

Journals

Cited by 9 publications

(2 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The electro-optical molecular parameters were substantiated at the level of E LUMO values which prove that the ground electronic state is more stabilized than the excited state. Filip et al [156][157] reported that the presence of substituents resulted in …”

Section: XLIXmentioning

confidence: 99%

Frontiers of Formazans Chemistry: A Review

Kumar¹

2017

WJPR

View full text Add to dashboard Cite

show abstract

Section: XLIXmentioning

confidence: 99%

Frontiers of Formazans Chemistry: A Review

Kumar¹

2017

WJPR

View full text Add to dashboard Cite

show abstract

“…A wide range of drugs can also alter the rate of their own metabolism, by induction or inhibition of drug metabolising enzyme activity. A key example is rifampicin (US: rifampin), a bactericidal antibiotic drug of the rifamycin group[48] used to treat tuberculosis and other serious infections. When rifampicin was…”

mentioning

confidence: 99%

Personalized Medicine: the Impact on Chemistry

Watkins

Marsh

Taylor

et al. 2010

Therapeutic Delivery

View full text Add to dashboard Cite

An effective strategy for personalized medicine requires a major conceptual change in the development and application of therapeutics. In this article, we argue that further advances in this field should be made with reference to another conceptual shift, that of network pharmacology. We examine the intersection of personalized medicine and network pharmacology to identify strategies for the development of personalized therapies that are fully informed by network pharmacology concepts. This provides a framework for discussion of the impact personalized medicine will have on chemistry in terms of drug discovery, formulation and delivery, the adaptations and changes in ideology required and the contribution chemistry is already making. New ways of conceptualising chemistry's relationship with medicine will lead to new approaches to drug discovery and hold the promise of delivering safer and more effective therapies.

show abstract